← FDA DRUG APPROVALS

FDA ANDA · ANDA079175

INDOMETHACIN

Sponsor: AVANTHI INC

APPLICATION
ANDA079175
TYPE
ANDA
ORIGINAL APPROVAL
2009-03-06
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

INDOMETHACINPrescription
INDOMETHACIN 75MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

2024-11-21Labeling · Supplement 21 · standardAP
2021-05-12Labeling · Supplement 13 · standardAP
2016-05-09Labeling · Supplement 7 · standardAP
2009-03-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →